glp-1 market news today Drug Market: the rapid growth of the diabetes and obesity drugs GLP-1 Drug Market: the rapid

This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio.

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

Get help with your weight management goals

As a health coach, I compare the pros & cons of these weight loss options

Recent research suggests that semaglutide, a medication primarily used for type 2 diabetes and weight management, may also help reduce alcohol consumption